Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects with Active Psoriatic Arthritis https://kusajili.fr:443/Trial/eFbsakBONU2pTYh0aXnolQ%24a-phase-3-multicenter-randomized-double-blind-placebo-controlled-parallel-group-efficacy-and-safety-study-of-two-doses-of-aprem
I have read and accept the terms of use of the site and the Privacy Policy
Send your message